October - 2018
| Previous Past Months | Showing Journal 3 of 3 |
Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical TrialR.P. Dellinger, S.M.Bagshaw, M Antonelli, et al for the EUPHRATES Trials Investigators JAMA, 2018, 320(14):1455-1463 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
October |
Previous Comments
No Comments yet.
Comment
We all know endotoxin is a problem - it activates the inflammatory response, leads to systemic damage external to primary infection sites, and can be hard to turn off.
We have tried to modify this and failed - monoclonal human and mouse antibody, recombinant bacterial...